These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 892928)
21. Radiolabelling of 4-iodo-N-(2-morpholinoethyl)benzamide with NA123I and NA125I. Tsopelas C Nucl Med Biol; 1999 Jul; 26(5):591-5. PubMed ID: 10473199 [No Abstract] [Full Text] [Related]
22. Updating the procedure for metaiodobenzylguanidine labelling with iodine radioisotopes employed in industrial production. Franceschini R; Mosca R; Bonino C J Nucl Biol Med (1991); 1991; 35(4):183-5. PubMed ID: 1823814 [TBL] [Abstract][Full Text] [Related]
23. A facile no-carrier-added radioiodination procedure suitable for radiolabeling kits. Kabalka GW; Mereddy AR Nucl Med Biol; 2004 Oct; 31(7):935-8. PubMed ID: 15464395 [TBL] [Abstract][Full Text] [Related]
25. Radioiodine labelled chenodeoxycholic acid: preparation and purity control. Ozker K; Urgancioğlu I Int J Appl Radiat Isot; 1982 Feb; 33(2):151-2. PubMed ID: 7061166 [No Abstract] [Full Text] [Related]
26. Synthesis of 123I-16-iodo-9-hexadecenoic acid and derivatives for use as myocardial perfusion imaging agents. Robinson GD Int J Appl Radiat Isot; 1977; 28(1-2):149-56. PubMed ID: 852908 [No Abstract] [Full Text] [Related]
27. Evaluation of a method for the preparation of high specific activity radioiodinated oestradiol. Thakur ML; Waters SL Int J Appl Radiat Isot; 1976 Oct; 27(10):585-8. PubMed ID: 992881 [No Abstract] [Full Text] [Related]
28. The use of IODO-GEN for preparing 125I-labeled peptides and their purification by reversed-phase high performance liquid chromatography. Conlon JM Methods Mol Biol; 1997; 73():231-7. PubMed ID: 9031211 [No Abstract] [Full Text] [Related]
32. Letter: Preparation of 125 I-fibrinogen. Welch MJ; Coleman RE; Sherman LA N Engl J Med; 1975 Jun; 292(23):1242. PubMed ID: 1128580 [No Abstract] [Full Text] [Related]
33. Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo. Bauwens M; Lahoutte T; Kersemans K; Gallez C; Bossuyt A; Mertens J Nucl Med Biol; 2006 Aug; 33(6):735-41. PubMed ID: 16934692 [TBL] [Abstract][Full Text] [Related]
34. Radioiodinated fatty acids for heart imaging: iodine monochloride addition compared with iodide replacement labeling. Robinson GD; Lee AW J Nucl Med; 1975 Jan; 16(1):17-21. PubMed ID: 1110400 [TBL] [Abstract][Full Text] [Related]
35. A versatile procedure for the radioiodination of proteins and labeling reagents. Davison PF Biochim Biophys Acta; 1987 Nov; 926(2):195-202. PubMed ID: 3663710 [TBL] [Abstract][Full Text] [Related]
36. Reaction of alpha-tubulin with iodotyrosines catalyzed by tubulin:tyrosine ligase: carboxy-terminal labeling of tubulin with [125I]monoiodotyrosine. Joniau M; Coudijzer K; De Cuyper M Anal Biochem; 1990 Feb; 184(2):325-9. PubMed ID: 2327576 [TBL] [Abstract][Full Text] [Related]
37. Radioiodination of human growth hormone with characterization and minimization of the commonly defined "damaged products". Bartolini P; De Assis LM; Fonseca ML Clin Chim Acta; 1981 Mar; 110(2-3):177-85. PubMed ID: 7226528 [TBL] [Abstract][Full Text] [Related]
38. Preparation of radioiodothyronines for tracer turnover studies in man. Bianchi R; Molea N; Cazzuola F; Fusani L; Mariani G J Nucl Med Allied Sci; 1981; 25(3):133-9. PubMed ID: 7310526 [No Abstract] [Full Text] [Related]
39. Preparation of active iodinated specific antibodies. Pagès JM; Louvard D; Lazdunski C FEBS Lett; 1975 Nov; 59(1):32-5. PubMed ID: 1225617 [No Abstract] [Full Text] [Related]
40. The electrolytic preparation of bioactive radioiodinated parathyroid hormone of high specific activity. Nielsen ST; Barrett PQ; Neuman MW; Neuman WF Anal Biochem; 1979 Jan; 92(1):67-73. PubMed ID: 426289 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]